HYDROSPAN
LIVE

Serial Number

79444223

Owner

Bausch Health Ireland Limited

Attorney

Jeremy Blackowicz

Filing Date

Dec 24, 2025

Add to watchlist:

No watchlists yet
View on USPTO

HYDROSPAN Trademark

Serial Number: 79444223

HYDROSPAN is a trademark filed by Bausch Health Ireland Limited on December 24, 2025. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently pending registration.

Owner Contact Info

Bausch Health Ireland Limited

3013 Lake Drive Citywest Business Campus

Entity Type: 99

Trademark Details

Filing Date

December 24, 2025

Registration Date

Not Registered

Published for Opposition

May 26, 2026

Goods & Services

pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of autoimmune conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of blood conditions, diseases and disorders; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the prevention and treatment of conditions, diseases, and disorders of the central and peripheral nervous system; pharmaceutical preparations for the prevention and treatment of dermatological conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of endocrine conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of gastrointestinal conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of hepatic conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of immunological conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of infectious diseases; pharmaceutical preparations for the prevention and treatment of inflammatory conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of metabolic conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of muscular conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of neurological conditions, diseases, and disorders; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the prevention and treatment of psychiatric conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of respiratory and pulmonary conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of renal conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of urological conditions, diseases, and disorders; pharmaceutical preparations for the prevention and treatment of viral diseases.

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 26, 2026 NPUB
PUBLISHED FOR OPPOSITION
May 26, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
May 20, 2026 NONP
REFUSAL PROCESSED BY IB
May 14, 2026 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 29, 2026 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 28, 2026 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 28, 2026 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 28, 2026 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Apr 26, 2026 RFCS
REFUSAL PROCESSED BY MPU
Apr 26, 2026 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Mar 14, 2026 RFCR
NON-FINAL ACTION WRITTEN
Mar 13, 2026 CNRT
ASSIGNED TO EXAMINER
Mar 11, 2026 DOCK
APPLICATION FILING RECEIPT MAILED
Feb 20, 2026 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 20, 2026 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 19, 2026 REPR